A loss-of-adhesion CRISPR-Cas9 screening platform to identify cell adhesion-regulatory proteins and signaling pathways.
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
19 04 2022
19 04 2022
Historique:
received:
26
03
2020
accepted:
04
04
2022
entrez:
20
4
2022
pubmed:
21
4
2022
medline:
22
4
2022
Statut:
epublish
Résumé
The clinical introduction of the Bruton's tyrosine kinase (BTK) inhibitor ibrutinib, which targets B-cell antigen-receptor (BCR)-controlled integrin-mediated retention of malignant B cells in their growth-supportive lymphoid organ microenvironment, provided a major breakthrough in lymphoma and leukemia treatment. Unfortunately, a significant subset of patients is intrinsically resistant or acquires resistance against ibrutinib. Here, to discover novel therapeutic targets, we present an unbiased loss-of-adhesion CRISPR-Cas9 knockout screening method to identify proteins involved in BCR-controlled integrin-mediated adhesion. Illustrating the validity of our approach, several kinases with an established role in BCR-controlled adhesion, including BTK and PI3K, both targets for clinically applied inhibitors, are among the top hits of our screen. We anticipate that pharmacological inhibitors of the identified targets, e.g. PAK2 and PTK2B/PYK2, may have great clinical potential as therapy for lymphoma and leukemia patients. Furthermore, this screening platform is highly flexible and can be easily adapted to identify cell adhesion-regulatory proteins and signaling pathways for other stimuli, adhesion molecules, and cell types.
Identifiants
pubmed: 35440579
doi: 10.1038/s41467-022-29835-y
pii: 10.1038/s41467-022-29835-y
pmc: PMC9018714
doi:
Substances chimiques
Integrins
0
Protein Kinase Inhibitors
0
Agammaglobulinaemia Tyrosine Kinase
EC 2.7.10.2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2136Informations de copyright
© 2022. The Author(s).
Références
Leuk Lymphoma. 2015;56(10):2779-86
pubmed: 25726955
Blood. 2017 Mar 16;129(11):1469-1479
pubmed: 28049639
Nat Biotechnol. 2016 Feb;34(2):184-191
pubmed: 26780180
N Engl J Med. 2013 Jul 4;369(1):32-42
pubmed: 23782158
N Engl J Med. 2014 Jun 12;370(24):2352-4
pubmed: 24869597
Methods Mol Biol. 2016;1470:49-73
pubmed: 27581284
Biologicals. 2016 May;44(3):129-38
pubmed: 27067447
Blood. 2015 Mar 26;125(13):2062-7
pubmed: 25573991
Nucleic Acids Res. 2019 May 7;47(8):e47
pubmed: 30783653
Oncogene. 2015 May 7;34(19):2426-36
pubmed: 24954503
J Exp Med. 2003 Nov 17;198(10):1539-50
pubmed: 14610042
Cell. 1995 Oct 20;83(2):301-11
pubmed: 7585947
N Engl J Med. 2014 Jun 12;370(24):2286-94
pubmed: 24869598
Blood. 2021 Sep 30;138(13):1099-1109
pubmed: 34320163
J Biol Chem. 2009 Aug 21;284(34):22865-77
pubmed: 19561089
Nat Protoc. 2009;4(8):1184-91
pubmed: 19617889
Nat Commun. 2016 May 20;7:11589
pubmed: 27199251
N Engl J Med. 2015 Apr 9;372(15):1430-40
pubmed: 25853747
Nat Rev Cancer. 2018 Mar;18(3):148-167
pubmed: 29348577
J Clin Oncol. 2013 Jan 1;31(1):88-94
pubmed: 23045577
N Engl J Med. 2013 Aug 8;369(6):507-16
pubmed: 23782157
N Engl J Med. 2015 Dec 17;373(25):2425-37
pubmed: 26639149
Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13075-80
pubmed: 20615965
Mol Cell Biol. 1994 Nov;14(11):7306-13
pubmed: 7935444
J Biol Chem. 1996 Apr 12;271(15):8564-9
pubmed: 8621483
Genome Biol. 2014;15(12):550
pubmed: 25516281
Nat Biotechnol. 2016 Jun;34(6):631-3
pubmed: 27111720
Blood. 2015 Apr 2;125(14):2306-9
pubmed: 25838279
Nat Biotechnol. 2019 Aug;37(8):907-915
pubmed: 31375807
PLoS One. 2016 Aug 03;11(8):e0160255
pubmed: 27487157
Cell Rep. 2016 Oct 18;17(4):1193-1205
pubmed: 27760321
Blood. 2016 Mar 24;127(12):1559-63
pubmed: 26764355
Genome Biol. 2014;15(12):554
pubmed: 25476604
Blood. 2012 Mar 15;119(11):2590-4
pubmed: 22279054
Elife. 2014 May 13;3:e02270
pubmed: 24843022
Blood. 2017 May 4;129(18):2519-2525
pubmed: 28235842
Haematologica. 2016 Mar;101(3):e111-5
pubmed: 26635033
Front Oncol. 2020 Oct 26;10:591577
pubmed: 33154951
Blood. 2014 May 29;123(22):3390-7
pubmed: 24615777
Cancers (Basel). 2020 May 28;12(6):
pubmed: 32481736
Clin Cancer Res. 2020 Aug 1;26(15):3918-3927
pubmed: 32209572
Cancer. 2019 Feb 15;125(4):559-574
pubmed: 30508305
Blood. 2013 Oct 3;122(14):2412-24
pubmed: 23940282
J Exp Med. 1998 Apr 20;187(8):1343-8
pubmed: 9547345
Mol Syst Biol. 2014 Jul 01;10:733
pubmed: 24987113
Blood. 2010 Apr 1;115(13):2578-85
pubmed: 19965662